-
-
-
-
-
-
-
Viridian Therapeutics Appoints New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs and Announces $185 Million Private Placement Financing
-
-
-
-
-
-
-
Viridian Therapeutics to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
Jefferies Assumes Viridian Therapeutic (VRDN) at Buy
56,497 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All